Join
Live feed
·
PRReleasevia Quantisnow
Portage Biotech Inc. logo

Portage Biotech Acquires Outstanding Minority Interest of Invariant Natural Killer T cell (iNKT) Agonist Platform

ByQuantisnow·Wall Street's wire, on your screen.
PRTG· Portage Biotech Inc.
Energy

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PRTG (Portage Biotech Inc.) and more on Quantisnow.